XML 38 R10.htm IDEA: XBRL DOCUMENT v3.6.0.2
Fair Value Measurements
12 Months Ended
Dec. 31, 2016
Fair Value Disclosures [Abstract]  
Fair Value Measurements
FAIR VALUE MEASUREMENTS
Financial assets and liabilities carried at fair value are classified and disclosed in one of the following three categories:
Level 1
Quoted market prices in active markets for identical assets or liabilities.
Level 2
Observable market-based inputs or unobservable inputs that are corroborated by market data.
Level 3
Unobservable inputs reflecting our assumptions or external inputs from active markets.
When applying the fair value principles in the valuation of assets and liabilities, we are required to maximize the use of quoted market prices and minimize the use of unobservable inputs. We calculate the fair value of our Level 1 and Level 2 instruments based on the exchange traded price of identical or similar instruments, where available, or based on other observable inputs taking into account our credit risk and that of our counterparties. Foreign currency exchange contracts and interest rate hedges are included in Level 2 as we use inputs other than quoted prices that are observable for the asset or liability. The Level 2 derivative instruments are primarily valued using standard calculations and models that use readily observable market data as their basis. Our Level 3 liabilities represent milestone payments for acquisitions. For certain Level 3 liabilities the Black-Scholes option pricing model was used to value the liabilities, while the fair value of other liabilities was estimated using a discounted cash flow technique. Significant unobservable inputs to this technique included our probability assessments related to the occurrence of certain triggering events, appropriately discounted considering the uncertainties associated with the obligation, which we estimate to be near 100%. We remeasure the fair value of our assets and liabilities each reporting period. We record the changes in fair value within selling, general and administrative expense and the changes in the time value of money within other income (expense), net.
Assets and Liabilities Measured at Fair Value
 
2016
2015
Cash and cash equivalents
$
3,316

$
3,379

Trading marketable securities
94

82

Level 1 - Assets
$
3,410

$
3,461

Available-for-sale marketable securities:
 
 
Corporate and asset-backed debt securities
$
25

$
214

Foreign government debt securities

96

United States agency debt securities
9

120

United States treasury debt securities
16

264

Certificates of deposit
18

8

Total available-for-sale marketable securities
$
68

$
702

Foreign currency exchange forward contracts
45

69

Interest rate swap asset
57

15

Level 2 - Assets
$
170

$
786

Total assets measured at fair value
$
3,580

$
4,247

 
 
 
Deferred compensation arrangements
$
94

$
82

Level 1 - Liabilities
$
94

$
82

Foreign currency exchange forward contracts
$
18

$
10

Interest rate swap liability

4

Level 2 - Liabilities
$
18

$
14

Contingent consideration:
 
 
Beginning balance
$
56

$
48

Additions
49

11

Change in estimate
(7
)

Settlements
(12
)
(3
)
Balance at the end of the period
$
86

$
56

Level 3 - Liabilities
$
86

$
56

Total liabilities measured at fair value
$
198

$
152


Fair Value of Available for Sale Securities by Maturity
 
2016
2015
Due in one year or less
$
36

$
588

Due after one year through three years
$
32

$
114


On December 31, 2016 the aggregate difference between the cost and fair value of available-for-sale marketable securities was nominal. Interest receivable was less than $1 and $2 in 2016 and 2015 related to our marketable security portfolio. The total of interest and marketable securities income was $29, $14, and $28 in 2016, 2015, and 2014. The amounts were included in other income (expense), net.
Less than 1% of our investments in available-for-sale marketable securities had a credit quality rating of less than A2 (Moody's), A (Standard & Poor's) and A (Fitch). We do not plan to sell the investments, and it is not more likely than not that we will be required to sell the investments before recovery of their amortized cost basis, which may be maturity. We do not consider these investments to be other-than-temporarily impaired on December 31, 2016. On December 31, 2016 substantially all our investments with unrealized losses that were not deemed to be other-than-temporarily impaired were in a continuous unrealized loss position for less than twelve months, and the losses were nominal.
Securities in a Continuous Unrealized Loss Position
 
Number of Investments
Fair Value
Corporate and Asset-Backed
33
$
11

United States Agency
8
5

United States Treasury
19
15

Certificate of Deposit
5
2

Total
65
$
33